[Federal Register Volume 70, Number 228 (Tuesday, November 29, 2005)]
[Notices]
[Page 71558]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E5-6609]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 3, 2005, American 
Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, 
made application by renewal to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the basic classes of 
controlled substances listed in Schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010).             I
Dimethyltryptamine (7435)..................   I
Dihydromorphine (9145).....................   I
Amphetamine (1100).........................   II
Methamphetamine (1105).....................   II
Lysergic acid diethylamide (7315).            II
Phencyclidine (7471).......................   II
Phenylacetone (8501).......................   II
Cocaine (9041).............................   II
Codeine (9050).............................   II
Oxycodone (9143)...........................   II
Hydromorphone (9150).......................   II
Benzoylecgonine (9180).....................   II
Ecgonine (9180)............................   II
Meperidine (9230)..........................   II
Metazocine (9240)..........................   II
Morphine (9300)............................   II
Thebaine (9333)............................   II
Oxymorphone (9652).........................   II
------------------------------------------------------------------------

    The company plans to manufacture in bulk, small quantities of the 
listed controlled substances as radiolabeled compounds.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Acting Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than January 30, 2006.

Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. E5-6609 Filed 11-28-05; 8:45 am]
BILLING CODE 4410-09-P